scholarly journals Rational design of a new cytarabine-based prodrug for highly efficient oral delivery of cytarabine

RSC Advances ◽  
2018 ◽  
Vol 8 (24) ◽  
pp. 13103-13111 ◽  
Author(s):  
Jing Zhang ◽  
Di Zhang ◽  
Xu Hu ◽  
Ruiling Liu ◽  
Zhonghao Li ◽  
...  

To overcome the drawbacks of cytarabine such as bad liposolubility and low bioavailability, we rationally designed a new cytarabine-based prodrug for oral cytarabine delivery, realizing significantly enhanced bioavailability for cancer therapy.

ACS Nano ◽  
2020 ◽  
Vol 14 (3) ◽  
pp. 3272-3280 ◽  
Author(s):  
Jizhuang Wang ◽  
Ze Xiong ◽  
Ming Liu ◽  
Xiao-meng Li ◽  
Jing Zheng ◽  
...  

Author(s):  
Shuo Wang ◽  
Xu Zhang ◽  
Xue Chang ◽  
Meng-Ya Zong ◽  
Cun-Zheng Fan ◽  
...  

2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Chung-Jen Chiang ◽  
Yan-Hong Hong

AbstractButyrate has a bioactive function to reduce carcinogenesis. To achieve targeted cancer therapy, this study developed bacterial cancer therapy (BCT) with butyrate as a payload. By metabolic engineering, Escherichia coli Nissle 1917 (EcN) was reprogrammed to synthesize butyrate (referred to as biobutyrate) and designated EcN-BUT. The adopted strategy includes construction of a synthetic pathway for biobutyrate and the rational design of central metabolism to increase the production of biobutyrate at the expense of acetate. With glucose, EcN-BUT produced primarily biobutyrate under the hypoxic condition. Furthermore, human colorectal cancer cell was administrated with the produced biobutyrate. It caused the cell cycle arrest at the G1 phase and induced the mitochondrial apoptosis pathway independent of p53. In the tumor-bearing mice, the injected EcN-BUT exhibited tumor-specific colonization and significantly reduced the tumor volume by 70%. Overall, this study opens a new avenue for BCT based on biobutyrate.


2022 ◽  
Vol 13 ◽  
pp. 100198
Author(s):  
Cheng Li ◽  
Zijin Luo ◽  
Lixia Yang ◽  
Jun Chen ◽  
Kai Cheng ◽  
...  

2014 ◽  
Vol 26 (12) ◽  
pp. 3693-3700 ◽  
Author(s):  
Na Lin ◽  
Juan Qiao ◽  
Lian Duan ◽  
Jie Xue ◽  
Liduo Wang

Sign in / Sign up

Export Citation Format

Share Document